Exploring Foreign Epitopes Recogniton in Personalized Medicines with Vibha Jawa
Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.
Chris Spivey, editorial director, speaks with Vibha Jawa, executive director at Bristol Myers Squibb, on foreign epitopes recognition in what should be fully human antibody therapies. Can HLA genotyping show which binding targets will be most effective per individual patient, or per T cell response predictor in terms of a reverse translation in the clinic? A tangent from our upcoming conversation focused on High Titer Vector Producing Cells.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
